Nyxoah (NASDAQ:NYXH) Trading Down 4.6% After Earnings Miss

Key Points

• Nyxoah's stock price dropped 4.6% to $6.27 after a disappointing earnings report, where they missed earnings per share estimates by one cent.
• The company reported revenue of $1.58 million, exceeding analyst estimates of $1.33 million, despite a negative net margin of 1,541.84%.
• Stifel Nicolaus has reduced their price target for Nyxoah from $15.00 to $14.00 while maintaining a "buy" rating, as the stock currently holds an average target price of $15.00 from several analysts.

Nyxoah SA (NASDAQ:NYXH - Get Free Report) shares traded down 4.6% during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $6.27 and last traded at $6.27. 242,912 shares traded hands during trading, an increase of 63% from the average session volume of 149,328 shares. The stock had previously closed at $6.57.

The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.62) by ($0.01). The company had revenue of $1.58 million for the quarter, compared to the consensus estimate of $1.33 million. Nyxoah had a negative return on equity of 79.18% and a negative net margin of 1,541.84%.

Hedge Funds Weigh In On Nyxoah

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vestal Point Capital LP bought a new position in shares of Nyxoah during the 4th quarter worth about $23,394,000. Franklin Resources Inc. boosted its position in shares of Nyxoah by 0.9% during the 2nd quarter. Franklin Resources Inc. now owns 294,990 shares of the company's stock worth $2,207,000 after purchasing an additional 2,655 shares in the last quarter. Kovack Advisors Inc. raised its holdings in shares of Nyxoah by 148.2% in the 2nd quarter. Kovack Advisors Inc. now owns 57,827 shares of the company's stock worth $433,000 after acquiring an additional 34,532 shares during the last quarter. Shay Capital LLC acquired a new stake in shares of Nyxoah in the 2nd quarter worth about $374,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Nyxoah in the 4th quarter worth about $187,000.

Nyxoah Stock Up 1.3%

The company has a debt-to-equity ratio of 0.29, a quick ratio of 3.35 and a current ratio of 2.63. The company has a market cap of $219.01 million, a price-to-earnings ratio of -2.80 and a beta of 1.61. The stock's fifty day moving average is $7.44 and its two-hundred day moving average is $7.87.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.